Supplemental Digital Content

Size: px
Start display at page:

Download "Supplemental Digital Content"

Transcription

1 CNS Drugs The Relationship between Benzodiazepine Use and Traffic Accidents A Systematic Literature Review Beitske E. Smink, et al. Supplemental Digital Content This Supplemental Digital Content contains the table referred to in the full version of this article, which can be found at Adis Data Information BV. All rights reserved.

2 First author (year of publication)* Country Study design Study population Study period Outcome Substances of interest (determinants) 'Benzodiazepine/Driving' France Case-control Injured crash involved road users (n Accident-related Ethanol, Collaborative Group (1993) total = 2852): responsible drivers (n injury, hospitalization = 1599) and non-responsible drivers yes/no and pedestrians injured (n =9 99) Exposure assessment Toxicological results (plasma) IMMORTAL R4.2 (2005) Netherlands Case-control Injured crash involved drivers admitted to a hospital (cases, n = 184) and randomly selected drivers (controls, n = 3779) Accident-related injury Ethanol,, tricyclic antidepressants, methadone, opiates, amphetamines, cannabis, cocaine Toxicological results (breath, serum,, questionnaire IMMORTAL R4.2 (2005) Norway Case-control Injured and killed drivers (cases, n = 87) and randomly selected drivers (controls, n = 410) IMMORTAL R4.2 (2005) UK Case-control Fatally injured drivers (cases, n = 22) and randomly selected drivers (controls, n = 1312) Adams JE (2003) USA Case-control Fatally injured crash involved road users (n = 255) Accident-related injury or death Fatal accidents (cases); (controls) Incidence and nature of pelvic fractures Ethanol, amphetamine,, cannabis, cocaine, ecstasy, opiates Ethanol,, codeine, other opiates, amphetamines, ecstasy, cannabis, cocaine Ethanol, cocaine, Toxicological results (breath, autopsy/blood samples, oral fluid) Toxicological results (breath, postmortem samples, oral fluid), questionnaire Ahlm K (2009) Sweden Case-control Fatally injured drivers (n = 56) and hospitalized non-fatally injured drivers (n = 144) (cases); (controls) Prevalence, crash and injury characteristics Barbone F (1998) UK Case cross-over drivers involved in a first road Accidents, severity of traffic accident, 916 ever users of injury, driver at fault Ethanol, 200 most commonly used pharmaceutical substances and illicit drugs, tricyclic antidepressants, selective serotonin-reuptake inhibitor, other psychoactive drugs, results breath test Barnas C (1992) Austria Case-control Victims of ski accidents (n = 402) Severity of injury Ethanol, Toxicological results (, questionnaire Binnie GAC (1983) UK Cohort Patients aged over 15 years of one practice (n = 410; 205 pairs of drug takers and controls) Bo O (1975) Norway Case-control Injured motor vehicle drivers (n = 74) and non-accident drivers attending routine medical check-ups (n = 204) Accidents, phenothiazines, antidepressants 1973 Accident-related injury Ethanol, diazepam plasma)

3 Bouchard J (2004) Canada Case-control Fatally injured drivers (n total = 855; cases who had been involved in prior collisions causing bodily injury n = 53, controls n = 802; cases who had been involved in prior collisions causing property damage n = 161, controls n = 694) Accidents with or Ethanol, cannabis, cocaines, without involvement in opiates, PCP,, prior collisions causing barbiturates, amphetamines bodily injury or property damage Bramness JG (2002) Norway Cross-sectional Suspected drivers under the influence of ethanol or only one benzodiazepine (n = 10,759 and 818 resp) Bramness JG (2003) Norway Cross-sectional Suspected drivers under the influence of only one benzodiazepine (n = 818) Christensen LQ (1990) Denmark Cross-sectional Drivers suspected for drug influence (n = 461) Clinical impairment Ethanol, Clinical impairment Accidents Barbiturates,, other sedatives, cyclic antidepressives, antiepileptics, neuroleptics, opioids, CNS stimulants, cannabinoids, remaining drugs Christophersen AS (1995) Norway Case-control Drivers involved in an injury accident and the Norwegian population 1993 Non-fatal accidents Ethanol, cannabinoids, amphetamines, cocaine,, and Norwegian statistics of barbiturates, opiates and sales other analgesic drugs, muscle relaxants, antiepileptics, neuroleptics, antidepressants, antihistamines Cimbura G (1982) Canada Case-control Fatally injured drivers (n = 401) and pedestrians (n = 83) Fatal accidents Ethanol, basic, neutral and acidic drugs urine and occasionally vitreous humor, stomach content, liver) Currie D (1995) UK Case-control Responsible (n = 163) and not responsible people (n = 66) involved in accidents and presenting at two hospitals 1992 Injurious accidents for which there were no evident external factors Ethanol, tricyclic antidepressants, serum)

4 Drummer OH (2004) Australia Case-control Responsible (n = 2701) and not responsible (n = 509) fatally injured drivers Fatal accidents in which the driver was culpable for the crash Ethanol,, amphetamine group (e.g. cocaine), opiate group, cannabinoid group, other psychoactive drugs, miscellaneous group (nonpsychoactive drugs) Dubois S (2008) Canada Case-control Drivers aged 20 years and over involved in fatal crashes in the United States (n = ) Potentially unsafe driving actions in relation to the crash Dussault S (2002) Canada Case-control Fatally injured drivers (cases, n = 354) and randomly selected drivers (controls, n = 5931) Engeland A (2007) Norway Cohort All Norwegians aged years between April 2004 and September 2005 (3.1 million): incidence of accidents in the exposed persontime compared with unexposed person-time French DD (2005) USA Cohort Patients at a Veterans Administration hospital system taking without concomitant drug use (n = 7522) and patients taking concomitant use of and other drugs (n = 6223) (preliminary results) Fatal accidents Ethanol, cannabis, cocaine,, opiates, barbiturates, amphetamines, PCP Accidents Opiates, (tranquilizers and hypnotics), NSAIDs, antiasthmatics, penicillins, calcium receptor antagonists Injury-related medical event Concomitant use of and other drugs Toxicological results (breath, blood, Garriott JC (1977) USA Case-control All motor vehicle-associated fatalities: drivers at fault (n = 105), drivers not at fault (n = 22), passengers (n = 58), pedestrians (n = 22) Gibson JE (2009) UK Case-crossover and case-series Individuals, aged years, involved in a motor vehicle crash (n = ) Gustavsen I (2008) Norway Cohort all Norwegians aged between January 7th 2004 until September 30th 2006 (3.1 million) Fatal accidents in which the driver was at fault Alcohol and drugs Motor vehicle crashes, non- hypnotics, beta-blockers, opioids, acetaminophen/opioid compound analgesics, tricyclic antidepressants, selective serotonin reuptake inhibitors, antihistamines Accidents Zopiclone, zolpidem, flunitrazepam, nitrazepam

5 Hebert C (2007) Canada Case-crossover compared to unmatched casecontrol See Hemmelgarn B (1997): drivers involved in an injurious crash (n = 5579) and controls (n = ). For case-crossover study: controls are cases during control periods Injurious motor vehicle crashes having a long elimination (>24h) and having a short elimination ( 24h) Hemmelgarn B (1997) Canada Nested case-control drivers (aged years) involved in an injurious crash (n=5579) and controls (13 256) Injurious motor vehicle crashes having a long elimination (>24 h) and having a short elimination ( 24 h) Honkanen R (1980) Finland Case-control Injured crash involved drivers presented at emergency departments (cases, n = 201) and randomly selected drivers at petrol stations (controls, n = 325) 1977 Accident-related injury Ethanol, psychotropic drugs (e.g. ) serum), interviews Jacobson B (1983) Sweden Case-series Traffic accident victims (drivers, cyclists or pedestrians over the age of 15 years) treated at two hospitals (n = 244) Jick H (1981) USA Case-control People aged years hospitalized for injuries suffered in an automobile accident (n = 244): fault drivers (n = 93), passengers (n = 66), others (n = 85) Accidents, AIS (injury severity) Ethanol and other drugs (e.g. ) Accident-related injury Analgesics, antihistamines, sedative/minor tranquilizer drugs, hypnotics, major tranquilizers, questionnaire Kirby J (1992) USA Case-control Injured drivers aged 15 years and older admitted to a trauma service (n = 201) Kuitunen T (1994) Finland Cross-sectional Drivers suspected to be driving under the influence of alcohol and/or drugs (n = 327) 1988 Incidence, ISS (injury severity) Ethanol, opiates, cocaine metabolite, amphetamines, barbiturates,, cannabinoids Performance on the clinical test for drunkenness (concentration related) ethanol, Kuitunen T (1994) Finland Cross-sectional Drivers tested positive for diazepam alone (n = 130) Performance on the clinical test for drunkenness (concentration related) Diazepam (acute and chronic use) Kurzthaler I (2003) Austria Case-control Patients injured in a traffic accident and admitted to the trauma surgery emergency room (n = 269) 1995 Incidence, trauma (injury severity) Ethanol, Kurzthaler I (2005) Austria Case-control Non-fatal injured patients admitted to the trauma surgery emergency room (n = 1611) 1995 Accident type and trauma (injury severity) Ethanol,

6 Leveille SG (1994) USA Matched case-control Members of a large Seattle-based health maintenance organization over age 65 years: drivers involved in injurious crashes (n = 234) and controls (n = 447) Levy RS (1996) USA Case-control All patients admitted to the orthopaedic service aged 14 years or older (n = 766; tox analysis n = 628 (82%)) Injurious collisions, cyclic antidepressants, opioids, sedating antihistamines Injury grade Ethanol, opiates, cocaine, barbiturates, amphetamines, cannabinoids,, phencyclidine toxicological results (blood, Longo MC (2000) Australia Case-control Culpable and not culpable injured car drivers (n = 2029) and motorcycle riders (n = 250) Longo MC (2001) Australia Case-control Culpable and not culpable injured drivers, benzodiazepine positive only (n = 68) MacDonald T (1999) UK Case cross-over See Barbone 1998, hospitalized patients with trauma (risk of trauma) Accidents in which drivers are judged culpable Accidents in which drivers are judged culpable Ethanol, cannabinoids,, stimulants Accidents, injury See Barbone 1998; in addition results of a previous study (the relation between benzodiazepine use and risk of hospitalization) MacPherson RD (1984) Australia Case-control Drivers subjected to evidential breath analysis with (n = 5011) and without (n = 9813) crash involvement McGwin G (2000) USA Population based casecontrol study Drivers aged 65 years and older: atfault drivers involved in crashes (n = 244), not at-fault drivers involved in crashes (n = 182) and drivers not involved in crashes (n = 475) Accidents 13 groups (e.g. analgesics, CNS depressant drugs, including a drug negative group) 1996 Accidents Medical condition, medications Breath analysis, self-reported "tablets, drugs, insulin or medicine" Telephone interviews Meulemans A (1998) Belgium Case-control Drivers, aged at least 14 years, involved in a traffic accident on a public road and entering by direct admission one of the selected emergency departments Missen A (1978) New Zealand Case-series Hospitalized drivers, fatally injured drivers, apprehended drivers with low blood alcohol levels, selected drivers (n = 1500) Prevalence, type of accidents and kind of injuries, characteristics of the victims Ethanol, amphetamines, barbiturates,, cannabinoids, cocaine, opiates, methadone, propoxyphene 3 year period Driving impairment Ethanol, diazepam and its major metabolite (Ndesmethyldiazepam)

7 Movig K (2004) Netherlands Case-control Injured drivers admitted to the emergency room of a hospital (cases, n = 110) and randomly selected drivers (controls, n = 816) Accident-related injury Ethanol, amphetamines, barbiturates,, cannabis, methadone, opiates, tricyclic antidepressants Toxicological results (serum, urine, breath) Mura P (2003) France Case-control Drivers involved in a non-fatal accident admitted to an emergency department (cases, n = 900) and patients attending the same emergency units for a non-traumatic reason (controls, n = 900) Non-fatal accident related injury Ethanol, cannabinoids, opiates, cocaine, metabolites, amphetamines, psychoactive therapeutic drugs Murray N (1960) USA Cohort Drivers taking methaminodiazepoxide (Librium) [n = 68] Unknown Unpredicted sideeffects (e.g. increased Methaminodiazepoxide road accident frequency in a period of 90 days) Not described Neutel CI (1995) Canada Cohort Adults over 20 years, included in the Saskatchewan Health Database: patients who filled prescriptions for a (n= ) and controls (n=97 862) Neutel CI (1995) Canada cohort Adults over 20 years, included in the Saskatchewan Health Database: patients who filled prescriptions for a (n= ) and controls (n=97 862) traffic accident injuries benzodiazepine hypnotics (triazolam, flurazepam) and benzodiazepine anxiolytics (oxazepam, lorazepam, diazepam) medical event, e.g. benzodiazepine hypnotics traffic accident injuries (triazolam, flurazepam) and benzodiazepine anxiolytics (oxazepam, lorazepam, diazepam) prescription data (first prescription in 6 months) prescription data Neutel CI (1998) Canada cohort Adults aged over 20 years, included in the Saskatchewan Health Database: new users cohort (n = ), repeat users cohort (n = ), combined controls (n = ) Injurious traffic accidents (age, benzodiazepine halflife, first-time/longterm related) Benzodiazepine hypnotics (triazolam, flurazepam) and benzodiazepine anxiolytics (oxazepam, lorazepam, diazepam) Oster G (1987) USA Cohort Benzodiazepine users (n = 7271) and nonusers (65 439) aged not over 65 years Oster G (1990) USA Cohort Benzodiazepine tranquillizer users (n = 4554) and users of drugs other than (n = ) 1986 Accidental injury requiring medical attention Accidental injury requiring medical attention Claims for Benzodiazepine tranquillizers Pharmacy claims

8 Ray WA (1992) USA Cohort Medicaid enrollees aged years of age who had a valid driver's licence: 2978 person-years of use and person-years of no psychoactive drug use and involvement in 495 injurious crashes Injurious crashes, cyclic antidepressants, oral opioid analgesics, antihistamines Rivara FP (1989) USA Case-control Fatally (n = 160) and nonfatally (n = 452) injured trauma victims 1986 AIS, ISS (injury severity) Ethanol, marijuana, cocaine, opiates, Rapoport MJ (2008) Canada Case-crossover Drivers with dementia aged 65 years and older (n = 8690) Motor vehicle collisions Psychotropic medication (antipsychotics, antidepressants, ) and control medications topical antifungals, topical corticosteroids) Sjogren H (1997) Sweden Case-control Fatally injured drivers (n = 111) and hospitalized injured motor vehicle drivers (n = 130) Skegg DCG (1979) UK Nested case-control Injured drivers in road accidents (n = 57) and matched controls (n = 1425) Prevalence, crash and injury characteristics Serious road accidents Ethanol, licit drugs (e.g. ) and illicit drugs Minor tranquilizers (e.g. ) and major tranquilizers (e.g. phenothiazines) Smink BE (2005) Netherlands Cross-sectional Crash involved drivers (n=993) Injury severity Ethanol, opiates, amphetamines, cocaine, methadone, cannabinoids,, barbiturates, tricyclic antidepressants Smink BE (2008) Netherlands Cross-sectional Suspected drivers under the influence of only (n = 171) Performance on field sobriety tests Smink BE (2008) Netherlands Nested case-control Injured car drivers admitted to a regional trauma center (n = 106) Injury severity Ethanol, amphetamines, barbiturates,, cannabis, cocaine, methadone, opiates, tricyclic antidepressants Stoduto G (1993) Canada Case-series Seriously nonfatally injured motor vehicle collision victims admitted to a Regional Trauma Unit (n = 854) Incidence, demographic, injury, crash characteristics Ethanol, various licit and illicit drugs (e.g. cannabinoids, cocaine,, opiates)

9 Tamblyn R (2005) Canada Cohort Persons aged 65 years and older (n = ): new users (n = ) and never users (n = ) during follow-up The first occurrence of a nonvertebral fracture, soft-tissue injury or accidentrelated hostpital admission Terhune K (1982) Report DOT HS Terhune K (1992) Report DOT HS USA Case-control Culpable and not culpable drivers injured in a motor vehicle accident and treated at a hospital (n = 497) USA Case-control Fatally injured drivers (n = 1882): responsible and responsible/contributory (n = 1503); not responsible, contributory/none, contributory (n = 371); unknown (n = 8) Vinkers DJ (2003) Netherlands Cohort Individuals aged 85 years or older: 465 person-years with use and 1339 person-years without use Wadsworth EJ (2003) UK Cohort Individuals who participated in the first phase of the Bristol Stress and Health Study (Smith et al. 2000) [n = 4673] Wadsworth EJK (2005) UK Cohort People selected at random from the 2001 electoral registers for Cardiff and Merthyr Tydfil Williams AF (1985) USA Case-series 15- to 34-year-old male fatally injured drivers (n = 440) Incidence and role in the accident (?) Incidence and role in the accident Ethanol and other drugs Major drugs of abuse and common prescription drugs (e.g. tranquilizers, sedatives) Death 1999 Accidents requiring medical attention, minor injuries and cognitive failures 2001 Accidents (e.g. road traffic accidents), injuries, cognitive failures Sleeping tablets, antidepressants Psychotropic medication (e.g. ) Questionnaire Questionnaire Fatal motor vehicle crashes in which the driver was responsible for the crash 23 drugs or drug groups * Readers are referred to the reference list of the full article (which can be found at for complete citation details of the publications listed in this table = benzodiazepines ISS = Injury Severity Score; AIS = Abbreviated Injury Scale; MAIS = Maximum Abbreviated Injury Severity; PCP = phencyclidine

Drug Profiles of Apprehended Drivers in Victoria

Drug Profiles of Apprehended Drivers in Victoria Drug Profiles of Apprehended Drivers in Victoria J Gerostamoulos, P McCaffrey, O H. Drummer and M Odell*. Victorian Institute of Forensic Medicine, Department of Forensic Medicine, Monash University, 57-83

More information

INVOLVEMENT OF DRUGS IN ACCIDENT CAUSATION

INVOLVEMENT OF DRUGS IN ACCIDENT CAUSATION INVOLVEMENT OF DRUGS IN ACCIDENT CAUSATION Jim GEROSTAMOULOS, Helen BATZIRIS, Olaf H. DRUMMER Victorian Institute of Forensic Medicine and Department of Forensic Medicine, Monash University, Southbank,

More information

Risk of Involvement of Medicinal Drugs in Traffic Crashes

Risk of Involvement of Medicinal Drugs in Traffic Crashes Risk of Involvement of Medicinal Drugs in Traffic Crashes OLAF H.DRUMMER Victorian Institute of Forensic Medicine & Department of Forensic Medicine, Monash University, 57-83 Kavanagh Street, Southbank,

More information

Alcohol and drugs among motorcycle riders compared with car and van drivers killed in road crashes in Norway during

Alcohol and drugs among motorcycle riders compared with car and van drivers killed in road crashes in Norway during Alcohol and drugs among motorcycle riders compared with car and van drivers killed in road crashes in Norway during 2001-2010 Asbjørg S. Christophersen and Hallvard Gjerde Norwegian Institute of Public

More information

4/27/2016. About CCSA. Impaired Driving Research at CCSA. Background. Presentation Overview. Lessons Learned

4/27/2016. About CCSA. Impaired Driving Research at CCSA. Background. Presentation Overview. Lessons Learned About CCSA Drug-Impaired Driving i in Canada: Lessons Learned International Conference on Urban Traffic Safety Amy Porath-Waller, Ph.D. April 26, 2016 CCSA is Canada s only agency with a legislated national

More information

Driving Under The Influence Of Drugs In Ireland: A Growing And Significant Danger

Driving Under The Influence Of Drugs In Ireland: A Growing And Significant Danger Driving Under The Influence Of Drugs In Ireland: A Growing And Significant Danger D.A.Cusack, G.Harrington, P.Furney, K.Flynn and C.P.Leavy Medical Bureau of Road Safety, Department of Forensic Medicine,

More information

Drug-Impaired Driving in Europe

Drug-Impaired Driving in Europe Drug-Impaired Driving in Europe What is the Drug-Impaired Driving Learning Centre (DIDLC)? The Drug Impaired Driving Learning Centre (DIDLC) is a fully bilingual, web-based educational resource that was

More information

Earlier arrests among apprehended drivers in Norway with heroin and ecstasy detection

Earlier arrests among apprehended drivers in Norway with heroin and ecstasy detection Earlier arrests among apprehended drivers in Norway with heroin and ecstasy detection A. S. Christophersen¹, A. M. Hausken¹ and S. Skurtveit¹ ² ¹National Institute of Forensic Toxicology, P.O. Box 495

More information

Drug use and the severity of a traffic accident

Drug use and the severity of a traffic accident Accident Analysis and Prevention 37 (2005) 427 433 Drug use and the severity of a traffic accident B.E. Smink a,, B. Ruiter a, K.J. Lusthof a, J.J. de Gier c,d, D.R.A. Uges b, A.C.G. Egberts d a Netherlands

More information

The Contribution of Alcohol and Other Drugs Among Fatally Injured Drivers in Quebec: Some Preliminary Results

The Contribution of Alcohol and Other Drugs Among Fatally Injured Drivers in Quebec: Some Preliminary Results The Contribution of Alcohol and Other Drugs Among Fatally Injured Drivers in Quebec: Some Preliminary Results C. Dussault 1, M. Brault 2, J. Bouchard 2 and A.M. Lemire 2 1 Evaluation, Research and Innovation,

More information

Cannabis and the Risk of Crash Involvement

Cannabis and the Risk of Crash Involvement Cannabis and the Risk of Crash Involvement Matthew Baldock Drugs have long been a focus of law enforcement in Australia but recent legislation in a number of Australian states now requires routine drug

More information

Findings of Drug Driving Expert Technical Panel

Findings of Drug Driving Expert Technical Panel Findings of Drug Driving Expert Technical Panel Dr Kim Wolff Chair Reader in Addiction Science King s College London 1 Background: Government in its response to the North review indicated: Driving while

More information

A substance that reduces pain and may or may not have psychoactive properties.

A substance that reduces pain and may or may not have psychoactive properties. GLOSSARY OF TERMS AMPHETAMINE-TYPE STIMULANTS (ATS) A group of substances, mostly synthetic, with closely related chemical structure which have, to varying degrees, a stimulating effect on the central

More information

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test Code Test Name Effective Date

More information

THE ROLE OF ALCOHOL, LICIT AND ILLICIT DRUGS IN TRAFFIC IN EASTERN EUROPE

THE ROLE OF ALCOHOL, LICIT AND ILLICIT DRUGS IN TRAFFIC IN EASTERN EUROPE THE ROLE OF ALCOHOL, LICIT AND ILLICIT DRUGS IN TRAFFIC IN EASTERN EUROPE T. Varga 1, M. Vali 2, R. Wachowiak 3, F. Longauer 4, M. Zorec-Karlovsek 5 1. Dept. of Forensic Medicine, University of Szeged,

More information

The Road Safety Monitor Drugs and Driving A DRIVING FORCE FOR SAFETY

The Road Safety Monitor Drugs and Driving A DRIVING FORCE FOR SAFETY The Road Safety Monitor 2002 Drugs and Driving T R I N R E F O A F F I C J U R Y S E A R C H U N D A T I O N A DRIVING FORCE FOR SAFETY The Traffic Injury The mission of the Traffic Injury (TIRF) is to

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Gomes T, Redelmeier DA, Juurlink DN, et al. Opiod dose and risk of road trauma in Canada: a populationbased study. JAMA Intern Med. Published online January 14, 2013. doi:10.1001/2013.jamainternmed.733.

More information

National Drug-Related Deaths Index

National Drug-Related Deaths Index HRB Bulletin Drug Deaths 2015 National Drug-Related Deaths Index 2004 to 2015 data Overview This update presents figures from the National Drug- Related Deaths Index (NDRDI) on deaths due to poisoning

More information

The benzodiazepine hangover: Next-day residual effects on driving performance.

The benzodiazepine hangover: Next-day residual effects on driving performance. The benzodiazepine hangover: Next-day residual effects on driving performance. Stefanie Leung, Faculty of Medicine, The University of Sydney Nicholas Lintzeris, Drug and Alcohol Services, South Eastern

More information

Concurrent Use of Benzodiazepines and Antidepressants and the Risk of Motor Vehicle Accident in Older Drivers: A Nested Case Control Study

Concurrent Use of Benzodiazepines and Antidepressants and the Risk of Motor Vehicle Accident in Older Drivers: A Nested Case Control Study Neurol Ther (2015) 4:39 51 DOI 10.1007/s40120-015-0026-0 ORIGINAL RESEARCH Concurrent Use of Benzodiazepines and Antidepressants and the Risk of Motor Vehicle Accident in Older Drivers: A Nested Case Control

More information

Road Safety Authority Annual International Road Safety Conference

Road Safety Authority Annual International Road Safety Conference Road Safety Authority Annual International Road Safety Conference Alcohol Tackling the crisis on our roads. Dublin Castle 1 st June 2017. Drink Driving It Has Not Gone Away You Know Professor Denis A.

More information

MARIJUANA USE AMONG DRIVERS IN CANADA,

MARIJUANA USE AMONG DRIVERS IN CANADA, T R A F F I C I N J U R Y R E S E A R C H F O U N D A T I O N MARIJUANA USE AMONG DRIVERS IN CANADA, 2000-2014 Traffic Injury Research Foundation, December 2017 Introduction Public concern about drug-impaired

More information

Clinical Impairment of Benzodiazepines Relation between Benzodiazepine Concentrations and Impairment in Apprehended Drivers.

Clinical Impairment of Benzodiazepines Relation between Benzodiazepine Concentrations and Impairment in Apprehended Drivers. Clinical Impairment of Benzodiazepines Relation between Benzodiazepine Concentrations and Impairment in Apprehended Drivers. 1 J.G. Bramness, 2 S. Skurtveit, and 1 J. Mørland 1 National Institute of Forensic

More information

ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS

ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS Barry K Logan PhD, DABFT National Director of Forensic Services, NMS Labs Willow Grove PA Disclaimer

More information

Scottish Blues- Benzodiazepines and Drug Related Deaths in Scotland

Scottish Blues- Benzodiazepines and Drug Related Deaths in Scotland Scottish Blues- Benzodiazepines and Drug Related Deaths in Scotland EMCDDA Sep. 25 th 2014 Dr Saket Priyadarshi Associate Medical Director NHS Greater Glasgow and Clyde Vice-Chair, National Forum on Drug

More information

Implications of benzodiazepines in drug related deaths

Implications of benzodiazepines in drug related deaths Implications of benzodiazepines in drug related deaths Analyses of the french special mortality register data (DRAMES) Dr Michel Mallaret CEIP-Addictovigilance Grenoble France Lisboa, october 15th 2014

More information

On-the-road driving tests and neurocognitive tests for measuring the effects of cannabis on driving

On-the-road driving tests and neurocognitive tests for measuring the effects of cannabis on driving On-the-road driving tests and neurocognitive tests for measuring the effects of cannabis on driving JG Ramaekers Dept Neuropsychology & Psychopharmacology, Faculty of Psychology & Neuroscience, Maastricht

More information

The Drug Testing Process. Employer or Practice

The Drug Testing Process. Employer or Practice Disclosures Clinical Professor, Jefferson Medical College BOD MROCC [Medical Review Officer Certification Council] BOD National Sleep Foundation BOD POEMS [Pennsylvania Occupational & Environmental Medicine

More information

The OAS Report. Issue Suicidal Thoughts, Suicide Attempts, Major Depressive Episode, and Substance Use among Adults.

The OAS Report. Issue Suicidal Thoughts, Suicide Attempts, Major Depressive Episode, and Substance Use among Adults. Office of Applied Studies The OAS Report Issue 34 2006 Suicidal Thoughts, Suicide Attempts, Major Depressive Episode, and Substance Use among Adults In Brief Among adults aged 18 or older who experienced

More information

FATAL POISONINGS BY MEDICINAL OPIOIDS IN FINLAND

FATAL POISONINGS BY MEDICINAL OPIOIDS IN FINLAND FATAL POISONINGS BY MEDICINAL OPIOIDS IN FINLAND ERKKI VUORI 12.-13.11.2012 HJELT INSTITUUTTI OIKEUSLÄÄKETIETEEN OSASTO FINLAND IS AN IDEAL COUNTRY FOR POST- MORTEM TOXICOLOGICAL INVESTIGATIONS High autopsy

More information

Introduction. The Netherlands:

Introduction. The Netherlands: MEDICINAL DRUGS AND DRIVING SAFETY: A GRADED-LEVEL SYSTEM FOR LABELING Hilka Wolshrijn, Johan J. De Gier, James F. O'Hanlon (Institute for Drugs, Safety and Behavior - University of Limburg) & Peter A.G.M.

More information

Marijuana use and car crash injury

Marijuana use and car crash injury RESEARCH REPORT Blackwell Science, LtdOxford, UKADDAddiction0965-2140 2005 Society for the Study of Addiction 100 Original Article Marijuana use and car crash injury Stephanie Blows et al. Marijuana use

More information

INTRODUCTION. The drugs-and-driving problem

INTRODUCTION. The drugs-and-driving problem INTRODUCTION The drugs-and-driving problem Following nearly three decades of progress on the alcohol-crash problem, safety advocates, policy-makers, legislators and enforcement agencies have begun to express

More information

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) 1 Policy #: 803 (PLH-803-02) Effective Date: NA Reviewed Date: 4/11/2008 Subject: URINE DRUG SCREENS Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) Approved by: Laboratory

More information

1/26/2016. These are my own thoughts! Safe Workplace Safe Workforce Proven benefits of Stay At Work / Return To Work Process (SAW/RTW)

1/26/2016. These are my own thoughts! Safe Workplace Safe Workforce Proven benefits of Stay At Work / Return To Work Process (SAW/RTW) Dr. Paul A. Farnan farnan@mail.ubc.ca HealthQuest Occupational Health Corporation Alliance Medical Monitoring I have no financial interests or affiliation with any pharmaceutical industry or manufacturer

More information

What is pregabalin? Pregabalin tablets. Pregabalin misuse. National Drug Treatment Centre Research. Administration

What is pregabalin? Pregabalin tablets. Pregabalin misuse. National Drug Treatment Centre Research. Administration What is pregabalin? Pregabalin is a prescription drug used to manage a number of long-term conditions, including epilepsy, neuropathic pain and generalised anxiety disorder. Similar to benzodiazepines,

More information

Driving Under the Influence of Non-Alcohol Drugs An Update. Part II: Experimental Studies

Driving Under the Influence of Non-Alcohol Drugs An Update. Part II: Experimental Studies Driving Under the Influence of Non-Alcohol Drugs An Update. Part II: Experimental Studies M. C. Strand*, H. Gjerde, J. Mørland Domain for Forensic Sciences Norwegian Institute of Public Health Oslo Norway

More information

VIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER

VIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER VIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER To promote and protect the health of all Virginians Fatal Drug Overdose Quarterly Report Edition 216.3 Publication Date: January 217 METHODS,

More information

Fatal traffic accidents in which no alcohol is detected: Are drugs related?

Fatal traffic accidents in which no alcohol is detected: Are drugs related? T2007 Seattle, Washington Fatal traffic accidents in which no alcohol is detected: Are drugs related? Rosario García-Repetto *, Mª Luisa Soria, Mª Paz Giménez and Carmen Jurado. National Institute of Toxicology

More information

Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082

Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082 Alcohol The alcohol of interest is ethanol. Ethanol has a sedative effect in the brain. Ethanol intoxication symptoms include blurred vision, slurred speech, poor coordination and difficulty thinking depending

More information

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population Adam S. Ptolemy 1, Colleen Murray 2, Edward Dunn 3,

More information

Alcohol and other drug use in New Zealand. drivers 2004 to 2009 EVALUATION OF THE AUROJECT

Alcohol and other drug use in New Zealand. drivers 2004 to 2009 EVALUATION OF THE AUROJECT Alcohol and other drug use in New Zealand drivers 2004 to 2009 EVALUATION OF THE AUROJECT Alcohol and other drug use in New Zealand drivers 2004 to 2009 Prepared by Dr Helen Poulsen Environmental Science

More information

The British Columbia Coroners Service is committed to conducting a thorough, independent examination of the factors contributing to death in order to

The British Columbia Coroners Service is committed to conducting a thorough, independent examination of the factors contributing to death in order to The British Columbia Coroners Service is committed to conducting a thorough, independent examination of the factors contributing to death in order to improve community safety and quality of life in the

More information

Alcohol and Drug Consumption by Québec Truck Drivers

Alcohol and Drug Consumption by Québec Truck Drivers Alcohol and Drug Consumption by Québec Truck Drivers A-M. Lemire 1, M. Montégiani 1 and C. Dussault 2 1 Highway Safety Research and Strategy, Société de l assurance automobile du Québec (SAAQ), 2 Evaluation,

More information

Driving and Pain. Guidance for Faculty of Pain Medicine Members

Driving and Pain. Guidance for Faculty of Pain Medicine Members Driving and Pain Guidance for Faculty of Pain Medicine Members Introduction Road traffic accidents remain a significant public health problem in the UK. In 2016 there were over 180,000 casualties resulting

More information

Legemiddelbruk og hoftebrudd

Legemiddelbruk og hoftebrudd Legemiddelbruk og hoftebrudd Oppsummering av ph.d. GerIT 05.04.16 LIS Marit Stordal Bakken Haraldsplass Diakonale Sykehus U N I V E R S I T Y O F B E R G E N Potentially inappropriate drug use and hip

More information

The association between exposure to a rear-end collision and future health complaints. Journal of Clinical Epidemiology, 54 (August, 2001)

The association between exposure to a rear-end collision and future health complaints. Journal of Clinical Epidemiology, 54 (August, 2001) 1 The association between exposure to a rear-end collision and future health complaints Journal of Clinical Epidemiology, 54 (August, 2001) 851-856 Anita Berglund, Lars Alfredsson, Irene Jensen, J. David

More information

Reducing cannabis-impaired driving: Is there sufficient evidence for drug-testing of drivers?

Reducing cannabis-impaired driving: Is there sufficient evidence for drug-testing of drivers? Reducing cannabis-impaired driving: Is there sufficient evidence for drug-testing of drivers? Author Hall, Wayne, Homel, Ross Published 2007 Journal Title Addiction DOI https://doi.org/10.1111/j.1360-0443.2007.02042.x

More information

Cozart DDS Drug Detection System On-site Saliva Drug Testing

Cozart DDS Drug Detection System On-site Saliva Drug Testing Cozart DDS Drug Detection System On-site Saliva Drug Testing www.siemens.com Siemens Healthcare Diagnostics Drug Testing, under the Cozart brand name, has more than a 10-year legacy of providing an extensive

More information

Review of Drug Impaired Driving Legislation (Victoria Dec 2000) and New Random Drug Driving Legislation Based on Oral Fluid Testing

Review of Drug Impaired Driving Legislation (Victoria Dec 2000) and New Random Drug Driving Legislation Based on Oral Fluid Testing Review of Drug Impaired Driving Legislation (Victoria Dec 2000) and New Random Drug Driving Legislation Based on Oral Fluid Testing P D Swann MC Boorman JJ Potter VicRoads Road Safety Department 60 Denmark

More information

The Road Safety Monitor. Drugs and Driving

The Road Safety Monitor. Drugs and Driving The Road Safety Monitor Drugs and Driving The Traffic Injury The mission of the Traffic Injury (TIRF) is to reduce traffic-related deaths and injuries. TIRF is a national, independent, charitable road

More information

MEDICAL POLICY Drug Testing

MEDICAL POLICY Drug Testing POLICY: PG0069 ORIGINAL EFFECTIVE: 01/01/11 LAST REVIEW: 11/13/18 MEDICAL POLICY Drug Testing GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each

More information

PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017

PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017 PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017 NAME OF GUIDELINE REASON FOR GUIDELINE WHAT THE GUIDELINE WILL ACHIEVE? WHO NEEDS TO KNOW ABOUT IT? Medicines Guideline: Hypnotic Medication Compliance with NICE

More information

Effects of Central Nervous System Depressants on Driving

Effects of Central Nervous System Depressants on Driving Effects of Central Nervous System Depressants on Driving What is the Drug-Impaired Driving Learning Centre (DIDLC)? The Drug Impaired Driving Learning Centre (DIDLC) is a fully bilingual, web-based educational

More information

Oral Fluid Drug Screening

Oral Fluid Drug Screening Policy Brief www.ccsa.ca www.ccdus.ca April 2018 Policy Brief Oral Fluid Drug Screening Key Considerations Screening for drugs in samples of oral fluid collected at roadside provides a viable means of

More information

Epidemiology of non medical use of prescription drugs. Kamran Niaz, Survey and Statistics Section, Policy Analysis and Research Branch

Epidemiology of non medical use of prescription drugs. Kamran Niaz, Survey and Statistics Section, Policy Analysis and Research Branch Epidemiology of non medical use of prescription drugs Kamran Niaz, Survey and Statistics Section, Policy Analysis and Research Branch Monitoring of the drug use situation: Annual reports questionnaire

More information

Benzodiazepines. Benzodiazepines

Benzodiazepines. Benzodiazepines : History 1950s - Invented by Swiss chemists who identified its sedative effects 1950s 60s - Chlordiazepoxide (Librium) marketed as a safer alternative to barbiturates; along with newer benzodiazepines

More information

Monitoring misuse of psychoactive medicines at the EMCDDA

Monitoring misuse of psychoactive medicines at the EMCDDA Monitoring misuse of psychoactive medicines at the EMCDDA Indicator prevalence and patterns of drug use among general population EMCDDA Annual Expert meeting 17-18 June 2014 2 Background Mandate The EMCDDA

More information

Controlled Substance Monitoring and Drugs of Abuse Testing Determination

Controlled Substance Monitoring and Drugs of Abuse Testing Determination CPT s: 80305 Drug test(s), presumptive, any number of drug classes, any number of devices or procedures (eg, immunoassay); capable of being read by direct optical observation only (eg, dipsticks, cups,

More information

European Guidelines for Workplace Drug Testing in Blood and Blood Spots

European Guidelines for Workplace Drug Testing in Blood and Blood Spots EWDTS European Workplace Drug Testing Society European Guidelines for Workplace Drug Testing in Blood and Blood Spots 9th EWDTS Symposium in Lisbon Wim Schielen 29-5-2015, Lisbon Updating project # 2 Current

More information

Drug-related deaths and deaths among drug users in Ireland figures from the National Drug-Related Deaths Index

Drug-related deaths and deaths among drug users in Ireland figures from the National Drug-Related Deaths Index Drug-related deaths and deaths among drug users in Ireland 2011 figures from the National Drug-Related Deaths Index January 2014 Summary of 2011 results This update presents figures from the National Drug-Related

More information

An Introduction to Forensic Toxicology

An Introduction to Forensic Toxicology An Introduction to Forensic Toxicology Jennifer Shea, PhD, FCACB Ken Obenson, MBBS MFFLM (UK) FRCPC (Anat) FRCPC (Forensic Path) Dip American Brd of Path (Anat & Clin/Cytopath/Forensic Path) April 11,

More information

Alcohol and Drug-Crash Problem in Canada 2012 Report

Alcohol and Drug-Crash Problem in Canada 2012 Report CCMTA Road Safety Research Report Series Alcohol and Drug-Crash Problem in Canada 2012 Report Prepared for the Canadian Council of Motor Transport Administrators by the Traffic Injury Research Foundation

More information

What Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital

What Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital What Your Drug Test Really Means Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital Disclosure There are no relevant financial relationships with commercial interests associated.

More information

Quest Diagnostics Drug Testing Index Full Year 2015 Tables

Quest Diagnostics Drug Testing Index Full Year 2015 Tables Quest Diagnostics Drug Testing Index Full Year 2015 Tables Table 1. Annual Positivity Rates Urine Drug Tests (For Combined U.S. Workforce) (More than 9.5 million tests from January to December 2015) Year

More information

Alcohol - A Review P&A PAPE & ASSOCIATES TOXICOLOGY REPORTER. Specializing in Toxicology. Premortem Alcohol Testing. Postmortem Alcohol Testing

Alcohol - A Review P&A PAPE & ASSOCIATES TOXICOLOGY REPORTER. Specializing in Toxicology. Premortem Alcohol Testing. Postmortem Alcohol Testing s Alcohol - A Review P&A PAPE & ASSOCIATES Specializing in Toxicology TOXICOLOGY REPORTER Premortem Alcohol Testing Postmortem Alcohol Testing Case Analysis Statements and Testimony Case-relevant records

More information

MEDICAL POLICY Drug Testing

MEDICAL POLICY Drug Testing POLICY: PG0069 ORIGINAL EFFECTIVE: 01/01/11 LAST REVIEW: 04/10/18 MEDICAL POLICY Drug Testing GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each

More information

Cross-reactivity reactivity in EMIT

Cross-reactivity reactivity in EMIT Blood Drug Analysis at the State Bureau of Investigation Crime Laboratory Richard W. Waggoner, Jr. Sample Requirements 2-10 ml gray top vacutainers At least 10 ml of urine sample for drug facilitated sexual

More information

Drug-related deaths and deaths among drug users in Ireland figures from the National Drug-Related Deaths Index

Drug-related deaths and deaths among drug users in Ireland figures from the National Drug-Related Deaths Index Drug-related deaths and deaths among drug users in Ireland 21 figures from the National Drug-Related Deaths Index January 213 Summary of 21 results This update presents figures from the National Drug-Related

More information

Neonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012)

Neonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012) Neonatal bstinence Syndrome Questions & nswers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012) For more information and to download a copy of the NS Clinical Practice Guidelines, please visit

More information

The prevalence and impairment effects of drugged driving in New Zealand June 2017

The prevalence and impairment effects of drugged driving in New Zealand June 2017 The prevalence and impairment effects of drugged driving in New Zealand June 2017 Nicola J Starkey and Samuel G Charlton School of Psychology University of Waikato, Hamilton NZ Transport Agency research

More information

Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K.

Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K. Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K. Logan FSF Emerging Forensic Scientist Award Oral Presentation Disclosure

More information

Interactions between Alcohol, Cannabis and Cocaine in Risks of Traffic Violations and Traffic Crashes

Interactions between Alcohol, Cannabis and Cocaine in Risks of Traffic Violations and Traffic Crashes Interactions between Alcohol, Cannabis and Cocaine in Risks of Traffic Violations and Traffic Crashes 1 M.Chipman, 2 S. Macdonald and 3 R. Mann 1 Department of Public Health Sciences, University of Toronto,

More information

Tranquilizers & Sedative-Hypnotics

Tranquilizers & Sedative-Hypnotics Tranquilizers & Sedative-Hypnotics 1 Tranquilizer or anxiolytic: Drugs used therapeutically to treat agitation or anxiety Sedative-Hypnotic: drugs used to sedate and aid in sleep Original sedatives (before

More information

Does ultram show up as an opiate

Does ultram show up as an opiate Search Does ultram show up as an opiate Tramadol ( Ultram ) is prescribed for treating moderate to severe pain in adults. 19-2-2018 I took Tramadol Hydrochloride for 6 months due to joint pain from my

More information

What is a DRE. Introduction to Drugged Driving

What is a DRE. Introduction to Drugged Driving Introduction to Drugged Driving What is a DRE DRE Training & Certification For a list of classes scheduled in 2016, click here. The DEC Program trains police officers and other approved public safety officials

More information

Cannabis, Cannabinoids and Driving

Cannabis, Cannabinoids and Driving Cannabis, Cannabinoids and Driving What is the affect of cannabinoids on driving. The FDA has the best answer. It s apparent that the FDA does not believe that the mere presence of cannabinoids or their

More information

The Drug Evaluation and Classification Program

The Drug Evaluation and Classification Program The Drug Evaluation and Classification Program International Association of Chiefs of Police Drug Evaluation and Classification (DEC) Program The Drug Evaluation and Classification (DEC) Program is a transportation

More information

Role of Cannabis in Motor Vehicle Crashes

Role of Cannabis in Motor Vehicle Crashes Epidemiologic Reviews Copyright 1999 by The Johns Hopkins University School of Hygiene and Public Health All rights reserved Vol. 21,. 2 Printed in U.S.A Role of Cannabis in Motor Vehicle Crashes Michael

More information

Drug Per Se Laws. Key Considerations. The Issue. April Policy Brief

Drug Per Se Laws. Key Considerations. The Issue.   April Policy Brief www.ccsa.ca www.ccdus.ca April 2018 Policy Brief Drug Per Se Laws Key Considerations Despite the inherent difficulties associated with establishing per se drug laws, there is sufficient evidence to move

More information

Is it Safe to Drive a Car when Treated with Anxiolytics? Evidence from onthe-road Driving Studies During Normal Traffic

Is it Safe to Drive a Car when Treated with Anxiolytics? Evidence from onthe-road Driving Studies During Normal Traffic Current Psychiatry Reviews, 2005, 1, 215-225 215 Is it Safe to Drive a Car when Treated with Anxiolytics? Evidence from onthe-road Driving Studies During Normal Traffic Joris C. Verster*, Dieuwke S. Veldhuijzen

More information

Alcohol and Drug-Crash Problem in Canada 2011 Report

Alcohol and Drug-Crash Problem in Canada 2011 Report CCMTA Road Safety Research Report Series Alcohol and Drug-Crash Problem in Canada 2011 Report Prepared for the Canadian Council of Motor Transport Administrators by the Traffic Injury Research Foundation

More information

Effects of Cannabis on Driving

Effects of Cannabis on Driving Effects of Cannabis on Driving What is the Drug-Impaired Driving Learning Centre (DIDLC)? The Drug Impaired Driving Learning Centre (DIDLC) is a fully bilingual, web-based educational resource that was

More information

Identifying and evaluating patterns of prescription opioid use and associated risks in Ontario, Canada Gomes, T.

Identifying and evaluating patterns of prescription opioid use and associated risks in Ontario, Canada Gomes, T. UvA-DARE (Digital Academic Repository) Identifying and evaluating patterns of prescription opioid use and associated risks in Ontario, Canada Gomes, T. Link to publication Citation for published version

More information

Drug Related Deaths in Highland

Drug Related Deaths in Highland Drug Related Deaths in Highland Carolyn Hunter-Rowe Research and Intelligence Specialist August 2017 Highland Alcohol and Drugs Partnership Larch House, Stoneyfield Business Park, Inverness, IV2 7PA Website:

More information

Soma (carisoprodol), Soma Compound (carisoprodol and aspirin), Soma Compound w/ Codeine (carisoprodol and aspirin and codeine)

Soma (carisoprodol), Soma Compound (carisoprodol and aspirin), Soma Compound w/ Codeine (carisoprodol and aspirin and codeine) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.75.07 Subject: Page: 1 of 7 Last Review Date: September 15, 2016 Description (carisoprodol), Compound

More information

Subject: Pain Management (Page 1 of 7)

Subject: Pain Management (Page 1 of 7) Subject: Pain Management (Page 1 of 7) Objectives: Managing pain and restoring function are basic goals in helping a patient with chronic non-cancer pain. Federal and state guidelines require that all

More information

Pain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX

Pain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX Pain Management and Compliance Toxicology Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX Prescription Drug Abuse: A National Problem Prescription drug abuse is a growing

More information

DRINK AND DRUG-RELATED DRIVING

DRINK AND DRUG-RELATED DRIVING DRINK AND DRUG-RELATED DRIVING Know the dangers We all know that drink driving, and driving while under the influence of drugs, is dangerous. But, even as this behaviour has become increasingly socially

More information

Designer drugs and road safety in Japan

Designer drugs and road safety in Japan TECHNICAL CONSULTATION ON DRUG USE AND ROAD SAFETY WHO/HQ, GENEVA, SWITZERLAND, SALLE C 17 18 DECEMBER 2014 Designer drugs and road safety in Japan Kazuko Okamura National Research Institute of Police

More information

Drug Driving in NSW: evidence-gathering, enforcement and education

Drug Driving in NSW: evidence-gathering, enforcement and education Drug Driving in NSW: evidence-gathering, enforcement and education Evan a, Bernard Carlon, Alice Ma, Hassan Raisianzadeh, Ralston Fernandes, and Louise Higgins-Whitton a All authors: Transport for NSW

More information

SYMPOSIUM REPORT. The Counterdrug Technology Assessment Center at The Office of National Drug Control Policy, Executive Office of the President

SYMPOSIUM REPORT. The Counterdrug Technology Assessment Center at The Office of National Drug Control Policy, Executive Office of the President DEVELOPING GLOBAL STRATEGIES FOR IDENTIFYING, PROSECUTING, AND TREATING DRUG-IMPAIRED DRIVERS SYMPOSIUM REPORT JUNE 2004 SPONSORED BY: The Counterdrug Technology Assessment Center at The Office of National

More information

Conflict of Interest Disclosure

Conflict of Interest Disclosure Patient Rx Drug Misuse and Abuse: Compliance Toxicology Monitoring in Clinical Practice Toxicology Staff Andrea Terrell, Ph.D., DABCC Chief Scientific Officer George Behonick, Ph.D., DABFT, Manager, FBU

More information

Soma (carisoprodol), Soma Compound (carisoprodol and aspirin), Soma Compound w/ Codeine (carisoprodol and aspirin and codeine)

Soma (carisoprodol), Soma Compound (carisoprodol and aspirin), Soma Compound w/ Codeine (carisoprodol and aspirin and codeine) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.75.07 Subject: Soma Page: 1 of 7 Last Review Date: September 15, 2017 Soma Description Soma (carisoprodol),

More information

Prevalence of cannabis-impaired driving and crash risk

Prevalence of cannabis-impaired driving and crash risk Prevalence of cannabis-impaired driving and crash risk Dr. Mark Asbridge Associate Professor, Department of Community Health and Epidemiology and Emergency Medicine, Dalhousie University & MADD Canada

More information

CANADIAN TRENDS IN BENZODIAZEPINE & ZOPICLONE USE

CANADIAN TRENDS IN BENZODIAZEPINE & ZOPICLONE USE CANADIAN TRENDS IN BENZODIAZEPINE & ZOPICLONE USE Aliya Kassam 1, Scott B Patten 2 1 Institute of Psychiatry, London, UK, 2 Department of Community Health Sciences, University of Calgary, Calgary, Alberta,

More information

Drug-Impaired Driving in the United States

Drug-Impaired Driving in the United States Drug-Impaired Driving in the United States What is the Drug-Impaired Driving Learning Centre (DIDLC)? The Drug Impaired Driving Learning Centre (DIDLC) is a fully bilingual, web-based educational resource

More information

Department of Drug Abuse Research and Method Development

Department of Drug Abuse Research and Method Development Department of Drug Abuse Research and Method Development Division of forensic sciences National Institute of Public Health Stig Tore Bogstrand, PhD, project leader Saranda Kabashi, MSc Vigdis Vindenes,

More information

Suite 300, Washington, DC Synopsis... One or more drugs were detected in 81 percent of440. male drivers, aged 15-34, killed in motor vehicle

Suite 300, Washington, DC Synopsis... One or more drugs were detected in 81 percent of440. male drivers, aged 15-34, killed in motor vehicle ARTICLES-GENERAL Drugs in Fatally Injured Young Male Drivers ALLAN F WILLIAMS, PhD MICHAEL A. PEAT, PhD DENNIS J. CROUCH, BS JOANN K. WELLS, BA BRYAN S. FINKLE, PhD Dr. Williams and Ms. Wells are with

More information

MINOR TRANQUILIZERS CHAPTER TWO : MINOR TRANQUILIZERS

MINOR TRANQUILIZERS CHAPTER TWO : MINOR TRANQUILIZERS MINOR TRANQUILIZERS 76. The term 'minor tranquilizers' was introduced into the scientific literature in the 1950s to distinguish the medicines prescribed to reduce anxiety and tension from the major tranquillizers,

More information